Search Result "tinibs"
Anlotinib-Induced Hypertension: Current Concepts and Future Prospects
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 3 Year: 2022 Page: 216-224
Author(s): Bing Lv,Jing Chen,Xiao-Liang Liu
Advances in Drug Therapy for Gastrointestinal Stromal Tumour
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 21 Year: 2024 Page: 3057-3073
Author(s):
An Appraisal on Synthetic and Medicinal Aspects of Fused Pyrimidines as Anti NeoplasticAgents
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 5 Year: 2023 Page: 525-561
Author(s):
Adjuvant Therapies of COVID-19 - A Literature Review
Journal: Coronaviruses
Volume: 2 Issue: 10 Year: 2021 Page: 7-16
Author(s): Naina Mohamed Pakkir Maideen
Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in AsthmaSecondary to Chronic Myeloid Leukemia with Hypereosinophilia
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 20 Issue: 4 Year: 2021 Page: 389-393
Author(s): Antonio Gidaro,Emanuele Salvi,Maria Cristina Carraro,Roberta Simona Rossi,Roberto Castelli
Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy
Journal: Letters in Drug Design & Discovery
Volume: 9 Issue: 1 Year: 2012 Page: 84-125
Author(s): Malleshappa N. Noolvi, Harun M. Patel
Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/ChalconeHybrids via the EGFR Inhibition Pathway
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 17 Year: 2023 Page: 1932-1943
Author(s): Heba A. Hassan,Hesham A. M. Gomaa,Bahaa G.M. Youssif,Alaa M. Hayalah
P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor
Journal: Drug Metabolism Letters
Volume: 4 Issue: 4 Year: 2010 Page: 202-212
Author(s): Johnny J. Yang, Mark N. Milton, Shaoxia Yu, Mingxiang Liao, Ning Liu, Jing-Tao Wu, Liang-Shang Gan, Suresh K. Balani, Frank W. Lee, Shimoga Prakash, Cindy Q. Xia
Treatment Advances in Lung Cancer with Leptomeningeal Metastasis
Journal: Current Cancer Drug Targets
Volume: 24 Issue: 9 Year: 2024 Page: 910-919
Author(s):
ND-16: A Novel Compound for Inhibiting the Growth of Cutaneous T CellLymphoma by Targeting JAK2
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 4 Year: 2022 Page: 328-339
Author(s):